NASDAQ$ANGO
AngioDynamics Inc · Q3 2020 earnings
Q3 2020 earnings · · Investor relations
Briefing
AngioDynamics' Q3 2020 financial results were announced, showing a net sales increase of 6.5% compared to the prior-year quarter.
AngioDynamics reported a 6.5% increase in net sales for the third quarter of fiscal year 2020, reaching $69.8 million. The company's gross margin was 57.8%, a slight decrease of 40 basis points year over year. The company experienced a net loss from continuing operations of $5.7 million, or a loss of $0.15 per share, while adjusted earnings per share were $0.01. Due to the uncertainty created by the COVID-19 pandemic, management is withdrawing its fiscal year 2020 financial guidance.
- Net sales increased 6.5% to $69.8 million compared to the prior-year quarter.
- Gross margin declined 40 basis points to 57.8% year over year.
- GAAP loss per share was $0.15, with adjusted earnings per share at $0.01.
- PATHFINDER I Registry was launched to evaluate the AURYON™ Atherectomy System's performance.
- Fiscal year 2020 financial guidance was withdrawn due to COVID-19 pandemic uncertainty.
Headline financials
Revenue & EPS history
AngioDynamics · Revenue · Quarterly
$69.8M
Revenue by segment
AngioDynamics · $78.7M total across 2 segments · Q1 2024
- Med Device$52.8M-10.0%67.1%
- Med Tech$25.9M+13.4%32.9%
Forward guidance
Due to the ongoing pandemic, health systems are prioritizing the care of COVID-19 patients, impacting certain procedures and creating uncertainty, leading management to withdraw its fiscal year 2020 financial guidance.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2020
-0.9%
Avg return
Earnings day
-2.4%
Avg return
5 days after
-3.7%
Avg return
30 days after
43%
28 / 65 earnings
Positive
+30.9%
Q2 2025
Best reaction
-26.2%
Q1 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | +5.0% | -5.0% | — | |
| Q2 2026 | -13.5% | -25.5% | -24.0% | |
| Q1 2026 | +6.1% | -0.2% | +8.7% | |
| Q4 2025 | -10.2% | -9.8% | -9.3% | |
| Q3 2025 | +12.4% | -3.6% | -3.8% | |
| Q2 2025 | +30.9% | +32.6% | +17.4% | |
| Q1 2025 | -20.3% | -23.1% | -12.7% | |
| Q4 2024 | +24.8% | +21.1% | +25.8% | |
| Q3 2024 | +15.6% | +14.6% | +3.1% | |
| Q2 2024 | -17.7% | -20.1% | -23.5% | |
| Q1 2024 | -5.9% | -7.2% | -10.4% | |
| Q4 2023 | -2.5% | -3.8% | -16.1% | |
| Q3 2023 | -17.1% | -23.3% | -33.3% | |
| Q2 2023 | +11.5% | -1.0% | -1.3% | |
| Q1 2023 | -26.2% | -38.0% | -34.8% | |
| Q4 2022 | +4.4% | +6.4% | +21.3% | |
| Q3 2022 | +9.8% | +7.2% | -8.7% | |
| Q2 2022 | -15.5% | -15.5% | -25.8% | |
| Q1 2022 | +12.6% | +17.8% | +22.4% | |
| Q4 2021 | -7.0% | -8.6% | -3.9% | |
| Q3 2021 | +12.3% | +11.1% | +16.3% | |
| Q2 2021 | +14.7% | +14.2% | +24.7% | |
| Q1 2021 | +13.0% | +7.8% | -0.1% | |
| Q4 2020 | -11.5% | -11.8% | -12.7% | |
| Q3 2020 | -2.7% | +2.3% | -0.6% | |
| Q2 2020 | -9.2% | -11.3% | -17.0% | |
| Q1 2020 | -17.6% | -17.6% | -13.7% | |
| Q4 2019 | +6.8% | +6.2% | -4.8% | |
| Q3 2019 | -7.7% | -8.2% | -18.4% | |
| Q2 2019 | +6.7% | +6.7% | +8.6% | |
| Q1 2019 | -10.3% | -12.9% | -17.0% | |
| Q4 2018 | -9.2% | -7.8% | -5.4% | |
| Q3 2018 | +3.2% | +8.9% | +16.4% | |
| Q2 2018 | -1.8% | -0.1% | +5.1% | |
| Q1 2018 | -8.9% | -9.1% | -8.4% | |
| Q4 2017 | -5.9% | -3.5% | +5.1% | |
| Q3 2017 | +0.3% | -1.3% | -10.2% | |
| Q2 2017 | +1.7% | +3.2% | -2.5% | |
| Q1 2017 | -4.5% | -0.1% | -8.4% | |
| Q4 2016 | +10.6% | +14.1% | +8.4% | |
| Q3 2016 | -2.1% | — | — | |
| Q2 2016 | -8.7% | — | — | |
| Q1 2016 | -8.8% | — | — | |
| Q4 2015 | -2.3% | — | — | |
| Q3 2015 | -6.1% | — | — | |
| Q2 2015 | -0.9% | — | — | |
| Q1 2015 | +3.8% | — | — | |
| Q4 2014 | -5.0% | — | — | |
| Q3 2014 | -1.5% | — | — | |
| Q2 2014 | +6.1% | — | — | |
| Q1 2014 | +5.3% | — | — | |
| Q4 2013 | +1.3% | — | — | |
| Q3 2013 | -7.4% | — | — | |
| Q2 2013 | -2.4% | — | — | |
| Q1 2013 | -8.8% | — | — | |
| Q4 2010 | -0.9% | — | — | |
| Q4 2012 | +4.0% | — | — | |
| Q3 2011 | -1.3% | — | — | |
| Q3 2012 | -1.3% | — | — | |
| Q2 2012 | -5.7% | — | — | |
| Q2 2011 | -5.7% | — | — | |
| Q1 2011 | +3.5% | — | — | |
| Q4 2011 | +3.5% | — | — | |
| Q1 2012 | +3.5% | — | — | |
| Q3 2010 | +0.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro